Pharmafile Logo
Pharmafocus logo
Advanced Search
11347696326_bac61dbf66_e

Theramex launches Femarelle to treat menopause symptoms

November 15, 2021
Sales and Marketing

Theramex recently announced that they have acquired the Femarelle ® product licence to treat menopause symptoms. The commercialisation agreement was reached …

News

Pfizer vaccine generates most antibodies, comparative study suggests

November 15, 2021
Sales and Marketing

Pfizer Inc. and BioNTech’s COVID-19 vaccine yielded the strongest immune response in a comparative study of four vaccines. The study, …

News

First patient dosed in tumour membrane immunotherapy trial

November 15, 2021
Sales and Marketing

Cytovation AS, a clinical stage immune-oncology company focused on the development of its first-in-class targeted tumour membrane immunotherapy, announced that …

News

Biogen’s Aduhelm shown to reduce clinical decline in Alzheimer’s disease

November 12, 2021
Medical Communications

New ADUHELM (aducanumab-avwa) Phase III data has shown a positive correlation between plasma p-tau reduction and less cognitive and functional …

News

Blood pressure drugs could protect against type 2 diabetes

November 12, 2021
Medical Communications

Researchers have found that blood pressure drugs may directly reduce people’s risk of type 2 diabetes, a condition that an …

News
mat-napo-pij34zrzeew-unsplash

Trial investigates whether immunosuppressant holiday boosts vaccine protection

November 12, 2021
Medical Communications

A trial has been launched to evaluate how to increase COVID-19 vaccine protection among vulnerable patients taking immunosuppressant drugs . …

News

Kintor Pharma begins Phase II trial of KX-826 for androgenetic alopecia treatment

November 12, 2021
Medical Communications

Kintor Pharma, a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, announced that the company has dosed the …

News

New experimental drug identified for pancreatic cancer treatment

November 11, 2021
Business Services

Professor Shudong Wang, Head of Drug Discovery and Development at the University of South Australia, is hoping to utilise the …

News

NICE recommends mogamulizumab for treatment of ultra-rare blood cancers

November 11, 2021
Business Services

NICE has recommended POTELIGEO (mogamulizumab), manufactured by Kyowa Kirin, as a treatment option for adults in England in Wales with …

News

Study shows cancer treatments could be repurposed as Alzheimer’s drugs

November 11, 2021
Business Services

A new study published in Science Advances has shared that cancer drugs can be repurposed as therapies to be tested …

News

New study confirms role of digital biomarkers in monitoring patients with multiple sclerosis

November 11, 2021
Business Services

Results from a clinical study, published by Ad Scientiam in ‘Multiple Sclerosis and Related Disorders, secure the place of  MSCopilot ® for the …

News

Pfizer ask FDA to authorise COVID booster in adults

November 10, 2021
Research and Development

Pfizer have requested that the FDA authorise booster shots of the COVID-19 vaccine in all Americans 18 and older, citing …

News

COMPASS Pathways announce positive results in clinical trial for treatment-resistant depression

November 10, 2021
Research and Development

COMPASS Pathways, a mental health care company dedicated to the acceleration of patient access to evidence-based innovation in mental health, …

News

Pleco Therapeutics partners with Hyloris to develop novel cancer agent

November 10, 2021
Research and Development

Specialty biopharma company, Pleco Therapeutics, have announced the beginning of a strategic collaboration with Hyloris Pharmaceuticals, to develop and commercialise …

News

UK government to add Bharat Biotech’s Covaxin to list of approved travel vaccines

November 9, 2021
Manufacturing and Production

The UK government has stated that Covaxin is to be added to its list of approved COVID-19 vaccines for international …

News
dna

Harvard researchers target specific cells with gene therapy

November 9, 2021
Manufacturing and Production

A new technique to turn therapeutic genes on in specifically targeted cells has been developed, a potential game-changer in the …

News

Regeneron’s COVID antibody drug provides long term protection in clinical trial

November 9, 2021
Manufacturing and Production

Regeneron Pharmaceuticals have said that a single dose of its antibody COVID cocktail reduces the risk of contracting the virus …

News

BIAL appoints Joerg Holenz as R&D General Manager

November 8, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bial, appointments

BIAL have announced the appointment of Jorg Holenz as R&D General Manager, replacing Patricio da Silva, who steps down after …

Appointment

Diabetes drug dapagliflozin recommended by NICE for chronic kidney disease

November 8, 2021
Sales and Marketing

A study published in the journal Lancet states that a common diabetes drug may be an option for treating chronic …

News

HLB’s liver cancer treatment awarded Orphan Drug Status by FDA

November 8, 2021
Sales and Marketing

HLB have announced that its anticancer drug candidate, rivoceranib, has been awarded Orphan Drug Status by the FDA. HLB is …

News
The Gateway to Local Adoption Series

Latest content

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026

European Medicines Agency recommended 104 medicines for approval in 2025

January 20, 2026